Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-06-02

Clinical Trial Update: Effectiveness of Trephination With Platelet Rich Plasma or Placebo in a Primary Meniscal Tear Treatment [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 trial evaluating the effectiveness of Trephination with platelet-rich plasma versus placebo in treating a primary meniscal tear has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trephination with Platelet Rich Plasma

Snippet

Sponsor: Centre of Postgraduate Medical Education | Conditions: Meniscus Lesion | Phase 2, Phase 3 | Status: COMPLETED